In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity
Authors:
- 16 October 2023
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 20 (11) , e202301210
Abstract
The novel benzothiazole sulfonate hybrid derivatives containing azomethine group were synthesized and characterized using 1H‐NMR, 13C‐NMR, and HR‐MS analysis. The potential enzyme inhibition activities against pancreatic lipase of the novel benzothiazole sulfonate hybrid derivatives containing azomethine group were screened with in vitro and in silico methods. IC50 values of compounds 5 b (23.89 μM), 5 i (28.87 μM), and 5 f (30.13±4.32) were found to be more effective pancreatic lipase inhibitors than orlistat (57.75 μM) in vitro studies. Also, the binding affinities of compounds 5 b (−8.7 kcal/mol), 5 i (−8.6 kcal/mol), and 5 f (−8.9 kcal/mol) were found potential inhibitors for pancreatic lipase in silico studies. In addition, the absorption distribution, metabolism, and excretion properties (ADME), molecular properties, toxicity estimation, and bioactivity scores of the synthesized compounds were scanned. It was found to have the ability to cross the brain‐blood barrier for compounds 5 a, 5 b, 5 c, and 5 d. All compounds were calculated to be taken orally as drugs, suitable for absorption in the intestinal tract and not carcinogenic, as well as very strongly bound to plasma proteins. Finally, compound 5 f was observed to be the best inhibitor for pancreatic lipase according to in vitro and in silico studies.Keywords
This publication has 36 references indexed in Scilit:
- Obesity and hypertensionPharmacological Research, 2017
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platformJournal of Cheminformatics, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Orlistat-Associated Adverse Effects and Drug InteractionsDrug Safety, 2008
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Human digestive and metabolic lipases—a brief reviewJournal of Molecular Catalysis B: Enzymatic, 2003
- Orlistat, a New Lipase Inhibitor for the Management of ObesityPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Obesity as a Chronic DiseaseJournal of the American Dietetic Association, 1998
- Lipase Activation by Nonionic DetergentsJournal of Biological Chemistry, 1996
- Structure of human pancreatic lipaseNature, 1990